Bioactive glass compositions
A bioactive glass composition, a method and an implant. The glass composition comprising SiO 2 , Na 2 O, K 2 O, CaO, and P 2 O 5 , having the following composition: SiO 2 48-52 wt-%, Na 2 O 9-15 wt-%, K 2 O 12-18 wt-%, CaO 10-16 wt-%, P 2 O 5 1-7 wt-%, TiO 2 0.2-2 wt-%, B 2 O 3 0-4 wt-%, and MgO 0-6 wt-%, wherein Na 2 O+K 2 O>25 wt-%, MgO+CaO>14 wt-%, and B 2 O 3 /P 2 O 5 >0.3.
1. A bioactive glass composition comprising 48.5-52.0 wt-% of SiO 2 , 11.1-12.0 wt % of Na 2 O, 15.0-17.1 wt-% of K 2 O, 12.7-15.2 wt-% of CaO, 2.7-3.8 wt-% of P 2 O 5 , 0.0-0.6 wt-% of TiO 2 , 1.0-1.4 wt-% of B 2 O 3 , and 2.8-3.3 wt-% of MgO;
wherein the bioactive glass composition is amorphous.
2. A bioactive glass composition according to claim 1 , comprising 51.0 wt-% of SiO 2 , 11.1 wt-% of Na 2 O, 16.2 wt-% of K 2 O, 13.8 wt-% of CaO, 3.1 wt-% of P 2 O 5 , 0.4 wt-% of TiO 2 , 1.3 wt-% of B 2 O 3 , and 3.1 wt-% of MgO.
3. A bioactive glass composition according to claim 1 , comprising 51.1 wt-% of SiO 2 , 11.1 wt-% of Na 2 O, 16.2 wt-% of K 2 O, 13.8 wt-% of CaO, 3.1 wt-% of P 2 O 5 , 0.4 wt-% of TiO 2 , 1.2 wt-% of B 2 O 3 , and 3.1 wt-% of MgO.
4. A bioactive glass composition according to claim 1 , comprising 50.6 wt-% of SiO 2 , 11.8 wt-% of Na 2 O, 16.3 wt-% of K 2 O, 13.0 wt-% of CaO, 3.3 wt-% of P 2 O 5 , 0.5 wt-% of TiO 2 , 1.4 wt-% of B 2 O 3 , and 3.1 wt-% of MgO.
5. A method for performing surgery, comprising the step of implanting a sintered scaffold comprising a bioactive glass composition according to claim 1 .
6. A method for manufacturing a bioactive glass composition, comprising the steps of:
selecting raw materials for the composition,
mixing the raw materials, and
melting the raw materials into a homogenous glass;
wherein the raw materials are selected such that the homogenous glass has a composition according to claim 1 .
7. An implant comprising a bioactive glass composition according to claim 1 .
8. An implant according to claim 7 , wherein the implant has at least a partly porous structure made of the bioactive glass composition.
9. An implant according to claim 8 , wherein the porous structure comprises sintered fibers.
10. An implant according to claim 7 , wherein the implant further comprises a polymer phase.
11. An implant according to claim 10 , wherein the implant comprises the bioactive glass composition coated at least partly with a polymer coating.
12. An implant according to claim 10 , wherein the implant comprises bioactive glass fibers embedded in a polymer matrix.
13. An implant according to claim 10 , wherein the bioactive glass composition comprises a coating on a biostable material of the implant.
14. An implant according to claim 7 , wherein the implant comprises at least one pyrrolidone.